BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  OvaScience Reports Second Quarter 2014 Financial Results

  August 7, 2014

   · 

  1 min read
• Pharm Country

  European Medicines Agency Accepts Application Seeking New Indication For Pfizer Inc.'s Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults

  August 7, 2014

   · 

  1 min read
• Policy

  Teva Pharmaceutical Industries Limited Comments On Receipt Of First Paragraph IV Notice For COPAXONE® 40 Mg/Ml (Glatiramer Acetate Injection) Formulation

  August 7, 2014

   · 

  1 min read
• Drug Development

  TapImmune Inc.'s New Clinical Trial In Advanced Stage Ovarian Cancer Expands The Use Of Folate Receptor Alpha Peptide Antigens

  August 7, 2014

   · 

  1 min read
• Business

  Atrion Reports Second Quarter Results

  August 7, 2014

   · 

  8 min read
• Pharm Country

  Kathy Giusti Of The Multiple Myeloma Research Foundation (MMRF) Named To Pharmavoice 100

  August 7, 2014

   · 

  1 min read
• Business

  DexCom Reports Second Quarter 2014 Financial Results

  August 7, 2014

   · 

  1 min read
• Business

  Interleukin Genetics Inc. Announces Conference Call To Discuss Second Quarter 2014 Results

  August 7, 2014

   · 

  1 min read
• Seward Introduces Additional Sample Handling Alternatives To Pipette Tips

  August 7, 2014

   · 

  3 min read
• Drug Development

  Collegium Pharmaceutical, Inc. Announces Positive Top-Line Data From Phase III Study of Oxycodone DETERx®, Its Abuse-Deterrent, Extended-Release Product For Chronic Pain

  August 7, 2014

   · 

  4 min read